Patrick Loehrer
Program Leader - Global Oncology · Indiana University School of Medicine
Credentials: · · · ·
History
- Present
Indiana University School of Medicine · St Jude Children's Research Hospital
- 1981–1983
Indiana University Medical Center
- 1974–1978
Research
Journal of Clinical Oncology · 2004 · 1,409 citations
New England Journal of Medicine · 1987 · Last of 6 authors · 1,031 citations
Drugs five years later. Cisplatin
Review · Annals of Internal Medicine · 1984 · First of 2 authors · 1,022 citations
77 papers
- CN
26 papers
23 papers
17 papers
- BR
14 papers
13 papers
13 papers
- EC
13 papers
Grants
- 2020–2026
The East Africa Consortium for HPV and Cervical Cancer in Women Living with HIV/AIDS
National Cancer Institute · U54
Contact PI · $4.7M · Indiana University Indianapolis
- 1999–2024
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $24.9M · Indiana University Indianapolis
- 2014–2021
AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS
National Cancer Institute · U54
Contact PI · $3.8M · Indiana University Indianapolis
- 1989–2016
Eastern Cooperative Oncology Group
National Cancer Institute · U10
Contact PI · $5.1M · Indiana University Indianapolis
Clinical trials
- 2019–2023
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
Principal investigator · Terminated · Phase 1
Patrick Joseph Loehrer Sr.
- 2014–2021
A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Principal investigator · Completed · Phase 2
Patrick Joseph Loehrer Sr.
- 2009–2014
Principal investigator · Completed
Indiana University
- 2008–2013
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)